Health Disparities in SLE

This lecture provides an overview of health disparities in lupus. Certain ethnic, gender and racial patient populations are prone to a higher incidence and prevalence of lupus and sometimes poorer quality health care than other Americans. Dr. Irene Blanco defines health disparities in systemic lupus erythematosus, discusses racial and ethnic health disparities as they pertain to SLE and identifies ways to recognize, address and reduce these disparities.

Expiration Date:
September 15, 2018

Course Credits:
0.5 hours

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The ACR designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This lecture targets the educational needs of internists, emergency medicine physicians, ophthalmologists, pediatricians, OB-GYNs and dermatologists to enhance early diagnosis, lessen symptom severity and improve quality of life of patients with lupus.

Originally released on April 22, 2011. Reviewed and re-released on September 15, 2015. Expires on September 15, 2018

0.5 hours

Certain ethnic, gender and racial patient populations are prone to a higher incidence and prevalence of lupus and sometimes poorer quality health care than other Americans. The health care system will have to change and adjust, as the nation’ population grows and diversifies, to meet the needs of an increasingly multicultural patient base.

Upon completion of this activity, participants should be able to:

  1. Define health disparities
  2. Discuss racial and ethnic health disparities as they pertain to Systemic Lupus Erythematosus
  3. Describe ways to identify, address and reduce health disparities based on race and ethnicity

Use of Professional Judgment
This activity, including all educational links, is intended to be used as a tool to assess the base knowledge of the learner. The information presented relates to basic principles of diagnosis and therapy, and is meant in no way to substitute for an individual patient assessment based upon the healthcare provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient.

Drugs and Doses
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule of contraindications.

ACR Disclosure Statement
The American College of Rheumatology is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern.

This project was supported by Grant Number 1CPIMP141065-01-00 from the U.S. Department of Health and Human Services office of Minority Health (HHS, OMH).  Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS, OMH.

Health Disparities in SLE Disclosures
Click here to view ACR’s ACCME disclosure practices.

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures:

Irene Blanco, MD, MS. Assistant Professor, Albert Einstein College of Medicine, Yeshiva University. No relevant financial relationship to disclose.

The Planning Committee Chairs, all planning committee members and/or staff who are in a position to influence content disclosures are as follows:

Greg Dennis, MD (Review Committee). Pharmaceutical Product Development, Bioprotection Systems Corporation. Dr. Dennis acknowledges the following relationship: Full-time employee, Pharmaceutical Product Development and Consultant, Bioprotection Systems Corporation.

Amanda Sammut, MD (Review Committee). Assistant Clinical Professor of Medicine, Columbia University Department of Medicine, Chief of Rheumatology Harlem Hospital Center. No relevant financial relationship to disclose.

Sam Lim, MD, MPH (Review Committee). Assistant Professor of Medicine and Epidemiology, Emory University. No relevant financial information to disclose

Anna Knippel. Director, Collaborative Initiatives. No relevant financial relationship to disclose

Sherry Williams, Esq. Founder and CEO, Hathor Strategic Consulting, Inc. No relevant financial relationship to disclose.

Disclosure information is considered accurate at the time of development. As needed, presenters will provide updated disclosure information to learners prior to content presentation.



  • Microsoft Internet Explorer V5.01 and higher
  • Recommendation is Internet Explorer 5.5 and higher

Operating System

  • Windows
  • Macintosh
  • Recommendation is Windows

Internet Connection

  • Broadband connection (DSL, cable or T1) recommended
  • While it is in the best interest of participants to take the exam through a broadband connection (DSL, cable or T1) rather than through a much slower dial-up connection, it is not an absolute requirement. Please realize that a dial-up connection may slow down the examination process.

Screen Resolution

  • 800 x 600 or better
  • 1024 x 768 is preferred

For technical support please complete the ACR online contact form.